Amalgamated Bank’s Bristol-Myers Squibb Co Position
Does Amalgamated Bank own Bristol-Myers Squibb Co (BMY)? Yes — 379.1K shares worth $23M (+0.18% of its 13F portfolio) as of Q1 2026, down from 388.0K shares the prior filed quarter.
Position Value
$23M
Q1 2026
Shares
379.1K
% of Portfolio
+0.18%
Quarters Held
29
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 379.1K | $23M | +0.18% |
| Q4 2025 | 388.0K | $21M | +0.15% |
| Q3 2025 | 408.9K | $18M | +0.13% |
| Q2 2025 | 413.4K | $19M | +0.15% |
| Q1 2025 | 400.9K | $24M | +0.21% |
| Q4 2024 | 397.2K | $22M | +0.18% |
| Q3 2024 | 398.4K | $21M | +0.17% |
| Q2 2024 | 409.9K | $17M | +0.14% |
| Q1 2024 | 422.2K | $23M | +0.20% |
| Q4 2023 | 494.3K | $25M | +0.20% |
| Q3 2023 | 530.4K | $31M | +0.26% |
| Q2 2023 | 541.8K | $35M | +0.28% |
| Q1 2023 | 595.5K | $41M | +0.35% |
| Q4 2022 | 558.2K | $40M | +0.36% |
| Q3 2022 | 577.1K | $41M | +0.40% |
| Q2 2022 | 543.7K | $42M | +0.39% |
| Q1 2022 | 578.1K | $42M | +0.33% |
| Q4 2021 | 626.0K | $39M | +0.29% |
| Q3 2021 | 603.3K | $36M | +0.30% |
| Q2 2021 | 628.4K | $42M | +0.34% |
| Q1 2021 | 129.2K | $8M | +0.31% |
| Q4 2020 | 134.7K | $8M | +0.32% |
| Q3 2020 | 135.1K | $8M | +0.35% |
| Q2 2020 | 138.5K | $8M | +0.38% |
| Q1 2020 | 372.2K | $21M | +0.51% |
| Q4 2019 | 384.9K | $25M | +0.45% |
| Q3 2019 | 248.0K | $13M | +0.26% |
| Q2 2019 | 227.7K | $10M | +0.24% |
| Q1 2019 | 228.2K | $11M | +0.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of BMY.